Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancer
Posted by admin December 23rd, 2008First study to examine the benefits of proton therapy versus standard treatment for lung cancer
CHICAGO – Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated radiation (IMRT) and concurrent chemotherapy, sildenafil medicine according to researchers from The University of Texas M. D. Anderson Cancer Center.
Read Full Article
